Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 20

Results For "NDMA"

214 News Found

Pharma manufacturer 'Gansons' turns 75
News | July 18, 2022

Pharma manufacturer 'Gansons' turns 75

Gansons is based in Thane (Maharashtra, India) with global representation in UK, USA, UAE, Central Asia, South Asia and South-East Asia.


India crosses ‘200 Crore’ COVID-19 vaccinations
News | July 18, 2022

India crosses ‘200 Crore’ COVID-19 vaccinations

PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive


USFDA approves Dupixent as first treatment for 12 and older with eosinophilic esophagitis
Drug Approval | May 21, 2022

USFDA approves Dupixent as first treatment for 12 and older with eosinophilic esophagitis

Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis in the United States; approval granted more than two months ahead of USFDA’s Priority Review action date


Bristol Myers Squibb highlights progress in treatment for cancer and blood disorders
Biotech | May 20, 2022

Bristol Myers Squibb highlights progress in treatment for cancer and blood disorders

First disclosure from PILOT study of Breyanzi in second-line large B-cell lymphoma underscores important role of cell therapy earlier in treatment paradigm


Roche extends commitment to the World Federation of Hemophilia Humanitarian Aid Program
News | May 10, 2022

Roche extends commitment to the World Federation of Hemophilia Humanitarian Aid Program

The renewed commitment will provide continued preventative (prophylactic) treatment to as many as 1,000 people with haemophilia A in locations where there is little to no access to haemophilia treatment


AI driven Israeli company Embryonics ties-up with Jaslok Hospital
Digitisation | April 19, 2022

AI driven Israeli company Embryonics ties-up with Jaslok Hospital

The data driven fertility company helps increase the success rate of fertility treatments


USFDA approves Yescarta as first CAR T-cell therapy for Lymphoma
Biotech | April 03, 2022

USFDA approves Yescarta as first CAR T-cell therapy for Lymphoma

Yescarta is First CAR T-cell therapy to receive NCCN treatment guideline category 1 recommendation --


Oppilotech and Evariste technologies partner for anti-bacterial programme
Biotech | March 16, 2022

Oppilotech and Evariste technologies partner for anti-bacterial programme

Machine learning approach to systems biology combined with ligand discovery platform


Aurobindo Pharma trains its managers to be `future ready’
News | March 11, 2022

Aurobindo Pharma trains its managers to be `future ready’

Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready


Jardiance is first and only treatment approved in Europe for chronic heart failure
Drug Approval | March 07, 2022

Jardiance is first and only treatment approved in Europe for chronic heart failure

The breakthrough approval expands the existing indication of Jardiance to include adults with heart failure with preserved ejection fraction (HFpEF), an underserved patient population that previously had no approved therapies in Europe